ClinicalTrials.Veeva

Menu

Plasma Protein Levels and Very Preterm Birth (ProHémie)

C

Centre Hospitalier Universitaire de la Réunion

Status

Completed

Conditions

Very Preterm Infants

Treatments

Other: Evaluation of the relationship plasma protein levels - neonatal hemodynamics

Study type

Observational

Funder types

Other

Identifiers

NCT02007902
2013/CHU/02
2013-A00090-45 (Other Identifier)

Details and patient eligibility

About

The primary aim of this study is to investigate the relationship between early plasma protein levels and hemodynamics in very preterm infants during postnatal transition. Secondary aims are the following: i) to evaluate maternal and neonatal factors affecting plasma protein level at birth; ii) to evaluate the relationship between plasma protein level and albumin level on the first day of life; iii) to evaluate the association between early hypoproteinemia and neonatal mortality and morbidity in very preterm infants.

Enrollment

125 patients

Sex

All

Ages

1 minute to 1 hour old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Parents written informed consent
  • Birth at less than 32 weeks of gestational age
  • Birth in a III level delivery facility at Reunion Island

Exclusion criteria

  • Major congenital abnormalities

Trial design

125 participants in 1 patient group

Very preterm babies
Description:
Observational model: cohort
Treatment:
Other: Evaluation of the relationship plasma protein levels - neonatal hemodynamics

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems